PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL OR PHARMACEUTICAL SALTS THEREOF AND DUTASTERIDE OR PHARMACEUTICAL SALTS THEREOF WITH NOVEL DISSOLUTION RATE
Provided is a pharmaceutical composition comprising as active ingredients: 5 mg of tadalafil or a pharmaceutically acceptable salt thereof; and 0.5 mg of dutasteride or a pharmaceutically acceptable salt thereof, wherein the dissolution rate of tadalafil under the dissolution conditions of a paddle...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English Korean |
Published |
07.07.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided is a pharmaceutical composition comprising as active ingredients: 5 mg of tadalafil or a pharmaceutically acceptable salt thereof; and 0.5 mg of dutasteride or a pharmaceutically acceptable salt thereof, wherein the dissolution rate of tadalafil under the dissolution conditions of a paddle rate of 50 rpm in 500 mL of a dissolution solution having a pH of 1.2 and containing 0.25% of SLS is 60 to 75 % after 5 minutes and 80 % or more after 30 minutes, and the dissolution rate of dutasteride under the dissolution conditions of a paddle rate of 50 rpm in 500 mL of a dissolution solution containing water and 0.1 % of SLS is 50 % or more after 15 minutes and 85 % or more after 30 minutes.
타다라필 또는 이의 약제학적으로 허용되는 염 5mg; 두타스테리드 또는 이의 약제학적으로 허용되는 염 0.5mg을 유효성분으로 포함하는 약제학적 조성물에 있어서, pH 1.2, 0.25% SLS를 포함하는 용출액 500mL에서 패들속도를 50rpm으로 하는 용출조건에서 타다라필의 용출률이 5분에 60~75% 및 30분에 80%이상의 용출률, 및 물, 0.1% SLS를 포함하는 용출액 500mL에서 패들속도를 50 rpm으로 하는 용출조건에서 두타스테리드의 용출률이 15분에 50% 이상 및 30분에 85%이상의 용출률을 나타내는 것을 특징으로 하는 약제학적 조성물이 제공된다. |
---|---|
Bibliography: | Application Number: KR20220072105 |